Topic: Molnupiravir

Dr. McCullough discusses the mechanisms of ivermectin, noting its ability to impair viral entry into the cell nucleus and its anti-spike protein properties. He compares it to Merck's new drug, molnupiravir, which he describes as having a slower, single mechanism of action. McCullough asserts that the intentional suppression of ivermectin was a strategy to promote fear and ensure the acceptance of a mass vaccination program and subsequent digital IDs.

Stu Peters discusses the rollout of Merck's new COVID-19 pill, Molnupiravir, as a response to widespread vaccine resistance. He claims that Big Pharma is attempting to replace Ivermectin with expensive, patented alternatives like "Pfizer-mectin." Peters argues that the pandemic would have ended naturally if the government had not intervened with "poisonous shots" that weaken the immune system.

Dr. Jane Ruby warns that Merck's Molnupiravir works by inducing "copy errors" in DNA, which she characterizes as a cancer-causing mechanism. She references whistleblower Rick Bright, who reportedly warned the Trump administration against fast-tracking the drug due to its mutagenic potential. Ruby claims the drug was tested "in vitro" and lacks long-term safety data regarding carcinogenic effects in humans.